579 related articles for article (PubMed ID: 25644835)
1. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylated LTR retrotransposon exhibits enhancer activity.
Hu T; Zhu X; Pi W; Yu M; Shi H; Tuan D
Epigenetics; 2017 Mar; 12(3):226-237. PubMed ID: 28165867
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation of Intragenic CpG Islands are Required for Differentiation from iPSC to NPC.
Choi WY; Hwang JH; Cho AN; Lee AJ; Lee J; Jung I; Cho SW; Kim LK; Kim YJ
Stem Cell Rev Rep; 2020 Dec; 16(6):1316-1327. PubMed ID: 32975781
[TBL] [Abstract][Full Text] [Related]
4. Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes.
Lee SM; Lee J; Noh KM; Choi WY; Jeon S; Oh GT; Kim-Ha J; Jin Y; Cho SW; Kim YJ
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1885-E1894. PubMed ID: 28223506
[TBL] [Abstract][Full Text] [Related]
5. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
Bae MG; Kim JY; Choi JK
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
[TBL] [Abstract][Full Text] [Related]
6. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
[TBL] [Abstract][Full Text] [Related]
7. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
[TBL] [Abstract][Full Text] [Related]
8. Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions.
Oyinlade O; Wei S; Kammers K; Liu S; Wang S; Ma D; Huang ZY; Qian J; Zhu H; Wan J; Xia S
Epigenetics; 2018; 13(7):751-768. PubMed ID: 30058478
[TBL] [Abstract][Full Text] [Related]
9. 5'-Hydroxymethylcytosine Precedes Loss of CpG Methylation in Enhancers and Genes Undergoing Activation in Cardiomyocyte Maturation.
Kranzhöfer DK; Gilsbach R; Grüning BA; Backofen R; Nührenberg TG; Hein L
PLoS One; 2016; 11(11):e0166575. PubMed ID: 27851806
[TBL] [Abstract][Full Text] [Related]
10. Developmentally linked human DNA hypermethylation is associated with down-modulation, repression, and upregulation of transcription.
Baribault C; Ehrlich KC; Ponnaluri VKC; Pradhan S; Lacey M; Ehrlich M
Epigenetics; 2018; 13(3):275-289. PubMed ID: 29498561
[TBL] [Abstract][Full Text] [Related]
11. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
14. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation.
Tejedor JR; Bueno C; Cobo I; Bayón GF; Prieto C; Mangas C; Pérez RF; Santamarina P; Urdinguio RG; Menéndez P; Fraga MF; Fernández AF
Epigenomics; 2018 Jul; 10(7):903-923. PubMed ID: 29620943
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
18. A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma.
Wong KY; Morgan GJ; Boyle EM; Cheng ASL; Yip KY; Chim CS
Sci Rep; 2021 Mar; 11(1):7009. PubMed ID: 33772052
[TBL] [Abstract][Full Text] [Related]
19. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
[TBL] [Abstract][Full Text] [Related]
20. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
